Douglas
G. Watson is the founder of Pittencrieff Glen
Associates, which was established in June, 1999.
Prior to this, he was President and Chief Executive Officer of
Novartis Corporation, the US subsidiary of Novartis A.G.
Mr.
Watson’s career spanned 33 years with Geigy / Ciba-Geigy / Novartis.
He joined Geigy (UK) Ltd in 1966, working first in Operations
Research and then in Corporate Planning.
Following the Ciba-Geigy merger, he spent one year in
Basel
,
Switzerland
as the
UK
representative to an international integration
team. He returned to
the
UK
in 1973 as accounting development and investment
appraisal manager, and subsequently headquarters management accountant.
In 1978, Doug returned to
Basel
as personal assistant to the Chairman of the
Executive Committee. In
1981, he joined the
US
Pharmaceuticals Division as senior vice president
of planning and business development, and a member of the
Pharmaceuticals Management Committee.
From 1986, he was President of Ciba Pharmaceuticals Division
until 1996, when he was appointed President & CEO of Ciba-Geigy
Corporation. During
this ten year period, Mr. Watson was an active member of the
Pharmaceutical Research & Manufacturers Association (PhRMA) board in
Washington
,
DC
.
Mr. Watson became President & CEO of Novartis Corporation in
1997 when Ciba-Geigy & Sandoz merged.
Mr Watson elected to take early retirement from Novartis in May,
1999.
Mr.
Watson,
in addition, is Chairman of the board of OraSure Technologies
Inc., and serves
as a member of the board of directors for Engelhard
Corporation,
Genta Inc., Dendreon Corporation,
BZL Biologics Inc.,
BioMimetic Pharmaceuticals Inc., BioElectronics Inc.,
InforMedix, Inc.,
and Innovative Drug Delivery Systems Inc.
Prior board memberships include Novartis Corporation, Summit Bank
Corporation, Principia Pharmaceuticals Inc., and ValiGen N.V.
He
has been a supporter of
America
’s Promise
since its inception, and is chairman of the Freedom House Foundation, a
non-profit organisation which treats adult men & women recovering
from alcohol and drug addiction. He is a member of the
Board of Directors of the American Liver Foundation, and on the
President's Advisory Council of
Drew
University
.
Born
near Pittencrieff Glen in the city of Dunfermline, Scotland, Mr. Watson
holds an MA degree in pure mathematics from Churchill College, Cambridge
University, and is a member of the Chartered Institute of Management
Accountants.
Useful
links to organisations referenced above:
America's
Promise
http://www.americaspromise.org
Freedom
House
http://www.freedomhouse.net
National
Health
Museum
http://www.nationalhealthmuseum.org
BioMimetics
Pharmaceuticals http://www.biomimetics.com
Dendreon
Corporation
http://www.dendreon.com
Engelhard
Corporation
http://www.engelhard.com
Genta
Incorporated
http://www.genta.com
Orasure
Technologies
http://www.orasure.com
